Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

Circulation

Volumn 106, Issue 4, 2002, Pages 484-490

  Tward, Aaron ^a   Xia, Yu Rong ^a   Wang, Xu Ping ^a   Shi, Yi Shou ^a   Park, Christina ^a   Castellani, Lawrence W ^a   Lusis, Aldons J ^a   Shih, Diana M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidants; Atherosclerosis; Free radicals; Genes; Lipoproteins

Indexed keywords

ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BACTERIAL CHROMOSOME; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; DOSE RESPONSE; DRUG TARGETING; ENZYME ACTIVITY; LIPID OXIDATION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NULL ALLELE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; ARYLDIALKYLPHOSPHATASE; CYTOPROTECTION; ESTERASES; HUMANS; LIPOPROTEINS, LDL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RNA, MESSENGER;

EID: 0037162376     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000023623.87083.4F     Document Type: Article

References (30)

1. Atherosclerosis
2. Atherosclerosis the road ahead
3. Low density lipoprotein oxidation and its pathobiological significance
4. Activation of NADPH oxidase required for macrophage-mediated oxidation of low-density lipoprotein
5. Plasma high density lipoproteins: Metabolism and relationship to atherogenesis
6. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its signal sequence
7. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45: Identity of K-45 with paraoxonase
8. Human serum paraoxonase/arylesterase
9. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: A possible peroxidative role for paraoxonase
10. Low serum paraoxonase: A risk factor for atherosclerotic disease?
11. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype
12. Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients
13. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
14. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis
15. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein
16. Antioxidants for vascular disease
17. Fatty acids, antioxidants, and coronary heart disease from an epidemiological perspective
18. Vitamin E and coronary artery disease
19. Lipoprotein oxidation, antioxidants and cardiovascular risk: Epidemiologic evidence
20. Prospective association between lipid soluble antioxidants and coronary heart disease in men: The Multiple Risk Factor Intervention Trial
21. Vitamin E and heart disease: Basic science to clinical intervention trials
22. Animal studies on antioxidants
23. Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite
24. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities
25. Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: Lessons from knockout mice
26. Moderate alcohol consumption and risk of heart failure among older persons
27. Daily moderate alcohol consumption increases serum paraoxonase activity: A diet-controlled, randomised intervention study in middle-aged men
28. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease
29. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
30. Flavonoids protect LDL from oxidation and attenuate atherosclerosis